Answers are grounded in this paper and cite their sources.
Amphetamines improved the severity of ADHD symptoms, as assessed by clinicians or patients, in the short term but did not improve retention to treatment. Amphetamines were associated with higher attrition due to adverse events. The short duration of studies coupled with their restrictive inclusion criteria limits the external validity of these findings. Furthermore, none of the included studies had an overall low risk of bias. Overall, the evidence generated by this review is of low or very low quality.
No takes yet. Share an insight, caveat, or question.
Castells et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: